1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Chronic Inflammatory Demyelinating Polyneuropathy: new trials by email Literature Review of Chronic Inflammatory Demyelinating Polyneuropathy trials Research Report on Chronic Inflammatory Demyelinating Polyneuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC Efgartigimod PH20 SC - Chronic Inflammatory Demyelinating Polyneuropathy | Phase 4 | Completed | argenx | 23 | 2024-12-10 | 2026-04-06 |
| IVIg for Demyelination in Diabetes Mellitus 10% intravenous immunoglobulin (IVIg), 0.9% sodium chloride - Peripheral Neuropathy, Diabetes Mellitus | Phase 4 | Unknown | University of Toronto | 25 | 2015-02-01 | 2016-11-11 |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (2) · Diabetes Mellitus (1) · Peripheral Nervous System Diseases (1)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Chronic Disease (2) · Demyelinating Diseases (2) · Disease Attributes (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Polyneuropathies (2) · Polyradiculoneuropathy (2) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1)
Immunoglobulins, Intravenous (1) · Saline Solution (1) · Sodium Chloride (1)
University of Toronto (1) · argenx (1)
Canada (1) · United States (1)